54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Jul 21
00:34 UTC
|
VALT
Valt Technology Services
|
◎ Target | firm only | Buy | GBX 7,100→ GBX 7,500+5.6% |
|
Jul 21
00:34 UTC
|
VALT
Valt Technology Services
|
◎ Target | firm only | Outperform | GBX 7,300→ GBX 7,200-1.4% |
|
Jul 21
00:34 UTC
|
VALE
Vale
|
◎ Target | Alfonso Salazar ★★☆☆☆ #2867 | Sec→ r Perform | $19.00→ $16.00-15.8% |
|
Jul 21
00:34 UTC
|
UWMC
UWM
|
◎ Target | Jeffrey Adelson ★★☆☆☆ #2341 | Equal Weight | $5.00→ $3.00-40.0% |
|
Jul 21
00:34 UTC
|
UNH
UnitedHealth Group
|
◎ Target | Andrew Mok not yet tracked | Overweight | $429.00→ $441.00+2.8% |
|
Jul 21
00:34 UTC
|
UHS
Universal Health Services
|
◎ Target | Jason Cassorla ★★★☆☆ #1154 | Buy | $211.00→ $195.00-7.6% |
|
Jul 21
00:34 UTC
|
TXN
Texas Instruments
|
◎ Target | Joseph Moore ★★★☆☆ #2142 | Underweight | $221.00→ $230.00+4.1% |
|
Jul 21
00:34 UTC
|
TWLO
Twilio
|
◎ Target | Ryan MacWilliams ★★★☆☆ #2034 | Overweight | $200.00→ $225.00+12.5% |
|
Jul 21
00:34 UTC
|
TWLO
Twilio
|
◎ Target | Patrick Walravens ★★★★★ #182 | Market Outperform | $210.00→ $250.00+19.0% |
|
Jul 21
00:34 UTC
|
TSCO
Tractor Supply
|
◎ Target | Justin Kleber ★★☆☆☆ #2734 | Outperform | $50.00→ $38.00-24.0% |
|
Jul 21
00:34 UTC
|
TRVI
Trevi Therapeutics
|
◎ Target | Brandon Folkes ★★☆☆☆ #2634 | Buy | $21.00→ $24.00+14.3% |
|
Jul 21
00:34 UTC
|
TRVI
Trevi Therapeutics
|
◎ Target | Mayank Mamtani ★★★☆☆ #1007 | Buy | $21.00→ $31.00+47.6% |
|
Jul 21
00:34 UTC
|
TRV
Travelers Companies
|
◎ Target | Mark Hughes ★★★☆☆ #1308 | Buy | $395.00→ $425.00+7.6% |
|
Jul 21
00:34 UTC
|
TRV
Travelers Companies
|
◎ Target | Matthew Heimermann ★★★★☆ #620 | Neutral | $315.00→ $385.00+22.2% |
|
Jul 21
00:34 UTC
|
TRV
Travelers Companies
|
◎ Target | Joshua Shanker ★★★☆☆ #2102 | Underperform | $283.00→ $307.00+8.5% |
|
Jul 21
00:34 UTC
|
TROW
T. Rowe Price Group
|
◎ Target | Bill Katz not yet tracked | Hold | $108.00→ $107.00-0.9% |
|
Jul 21
00:34 UTC
|
TMUS
T-Mobile US
|
◎ Target | Jonathan Atkin ★★★☆☆ #1587 | Outperform | $240.00→ $230.00-4.2% |
|
Jul 21
00:34 UTC
|
TLN
Talen Energy
|
◎ Target | Paul Zimbardo not yet tracked | Hold | $453.00→ $422.00-6.8% |
|
Jul 21
00:34 UTC
|
THRM
Gentherm
|
◎ Target | Nathan Jones ★★☆☆☆ #2467 | Buy | $38.00→ $44.00+15.8% |
|
Jul 21
00:34 UTC
|
THC
Tenet Healthcare
|
◎ Target | Jason Cassorla ★★★☆☆ #1154 | Buy | $252.00→ $242.00-4.0% |
|
Jul 21
00:34 UTC
|
TGT
Target
|
◎ Target | John Heinbockel ★★★☆☆ #1735 | Buy | $145.00→ $150.00+3.4% |
|
Jul 21
00:34 UTC
|
TFC
Truist Financial
|
◎ Target | David George ★★★★☆ #558 | Neutral | $55.00→ $56.00+1.8% |
|
Jul 21
00:34 UTC
|
TFC
Truist Financial
|
◎ Target | Christopher McGratty ★★★☆☆ #1557 | Market Perform | $53.00→ $55.00+3.8% |
|
Jul 21
00:34 UTC
|
TEX
Terex
|
◎ Target | Adam Seiden ★★☆☆☆ #2525 | Overweight | $65.00→ $70.00+7.7% |
|
Jul 21
00:34 UTC
|
TER
Teradyne
|
◎ Target | Timothy Arcuri ★★☆☆☆ #2458 | Buy | $440.00→ $500.00+13.6% |
|
Jul 21
00:34 UTC
|
TALO
Talos Energy
|
◎ Target | Paul Diamond not yet tracked | Buy | $20.00→ $18.00-10.0% |
|
Jul 21
00:34 UTC
|
T
AT&T
|
◎ Target | Jonathan Atkin ★★★☆☆ #1587 | Outperform | $31.00→ $27.00-12.9% |
|
Jul 21
00:34 UTC
|
SSNC
SS&C Technologies
|
◎ Target | Surinder Thind ★★★☆☆ #1365 | Buy | $92.00→ $83.00-9.8% |
|
Jul 21
00:34 UTC
|
SSNC
SS&C Technologies
|
◎ Target | Alexei Gogolev ★★★☆☆ #1092 | Neutral | $94.00→ $87.00-7.4% |
|
Jul 21
00:34 UTC
|
SPGI
S&P Global
|
◎ Target | Andrew Steinerman ★★★★☆ #772 | Overweight | $535.00→ $555.00+3.7% |
|
Jul 21
00:34 UTC
|
SLM
SLM
|
◎ Target | Jeffery Harte not yet tracked | Equal Weight | $27.00→ $28.00+3.7% |
|
Jul 21
00:34 UTC
|
SG
Sweetgreen
|
◎ Target | Jon Tower ★★★☆☆ #1651 | Buy | $9.00→ $10.00+11.1% |
|
Jul 21
00:34 UTC
|
SFNC
Simmons First National
|
◎ Target | Wood Lay ★★★★☆ #326 | Market Perform | $24.00→ $25.00+4.2% |
|
Jul 21
00:34 UTC
|
SEDG
SolarEdge Technologies
|
◎ Target | Jeff Osborne ★★☆☆☆ #2741 | Buy | $85.00→ $75.00-11.8% |
|
Jul 21
00:34 UTC
|
SCM
Stellus Capital Investment
|
◎ Target | Paul Johnson ★★★★☆ #392 | Market Perform | $9.00→ $8.00-11.1% |
|
Jul 21
00:34 UTC
|
RVMD
Revolution Medicines
|
◎ Target | Ami Fadia ★★☆☆☆ #2557 | Buy | $235.00→ $236.00+0.4% |
|
Jul 21
00:34 UTC
|
RSI
Rush Street Interactive
|
◎ Target | Zachary Silverberg ★☆☆☆☆ #3172 | Overweight | $29.00→ $35.00+20.7% |
|
Jul 21
00:34 UTC
|
RRR
Red Rock Resorts
|
◎ Target | Shaun Kelley ★★☆☆☆ #2347 | Neutral | $60.00→ $70.00+16.7% |
|
Jul 21
00:34 UTC
|
RRR
Red Rock Resorts
|
◎ Target | Barry Jonas ★★★☆☆ #1171 | Buy | $68.00→ $75.00+10.3% |
|
Jul 21
00:34 UTC
|
RNR
RenaissanceRe
|
◎ Target | Jimmy Bhullar ★★★★★ #22 | Neutral | $329.00→ $360.00+9.4% |
|
Jul 21
00:34 UTC
|
RLJ
RLJ Lodging Trust
|
◎ Target | Shaun Kelley ★★☆☆☆ #2347 | Underperform | $9.25→ $10.50+13.5% |
|
Jul 21
00:34 UTC
|
RF
Regions Financial
|
◎ Target | Peter Winter ★★★★☆ #797 | Neutral | $33.00→ $34.00+3.0% |
|
Jul 21
00:34 UTC
|
RF
Regions Financial
|
◎ Target | Benjamin Gerlinger not yet tracked | Buy | $32.00→ $36.00+12.5% |
|
Jul 21
00:34 UTC
|
RF
Regions Financial
|
◎ Target | Christopher McGratty ★★★☆☆ #1557 | Market Perform | $32.00→ $33.00+3.1% |
|
Jul 21
00:34 UTC
|
RCUS
Arcus Biosciences
|
◎ Target | Emily Bodnar ★★★☆☆ #2029 | Buy | $32.00→ $45.00+40.6% |
|
Jul 21
00:34 UTC
|
PTCT
PTC Therapeutics
|
◎ Target | Benjamin Burnett ★★☆☆☆ #2727 | Overweight | $95.00→ $93.00-2.1% |
|
Jul 21
00:34 UTC
|
PSNL
Personalis
|
◎ Target | Mark Massaro ★★★★☆ #742 | Buy | $11.00→ $16.25+47.7% |
|
Jul 21
00:34 UTC
|
PS
Pershing Square
|
◎ Target | Robert Ryan not yet tracked | Equal Weight | $37.00→ $34.00-8.1% |
|
Jul 21
00:34 UTC
|
PPL
PPL
|
◎ Target | Ross Fowler ★★★★☆ #662 | Buy | $42.00→ $39.00-7.1% |
|
Jul 21
00:34 UTC
|
POST
Post
|
◎ Target | Thomas Palmer ★★★☆☆ #1367 | Overweight | $119.00→ $116.00-2.5% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.